Literature DB >> 32181683

Tumor Copy Number Deconvolution Integrating Bulk and Single-Cell Sequencing Data.

Haoyun Lei1, Bochuan Lyu2, E Michael Gertz3,4, Alejandro A Schäffer3,4, Xulian Shi5, Kui Wu5, Guibo Li5, Liqin Xu5, Yong Hou5, Michael Dean6, Russell Schwartz1,7.   

Abstract

Characterizing intratumor heterogeneity (ITH) is crucial to understanding cancer development, but it is hampered by limits of available data sources. Bulk DNA sequencing is the most common technology to assess ITH, but involves the analysis of a mixture of many genetically distinct cells in each sample, which must then be computationally deconvolved. Single-cell sequencing is a promising alternative, but its limitations-for example, high noise, difficulty scaling to large populations, technical artifacts, and large data sets-have so far made it impractical for studying cohorts of sufficient size to identify statistically robust features of tumor evolution. We have developed strategies for deconvolution and tumor phylogenetics combining limited amounts of bulk and single-cell data to gain some advantages of single-cell resolution with much lower cost, with specific focus on deconvolving genomic copy number data. We developed a mixed membership model for clonal deconvolution via non-negative matrix factorization balancing deconvolution quality with similarity to single-cell samples via an associated efficient coordinate descent algorithm. We then improve on that algorithm by integrating deconvolution with clonal phylogeny inference, using a mixed integer linear programming model to incorporate a minimum evolution phylogenetic tree cost in the problem objective. We demonstrate the effectiveness of these methods on semisimulated data of known ground truth, showing improved deconvolution accuracy relative to bulk data alone.

Entities:  

Keywords:  cancer; copy number alteration (CNA); genomic deconvolution; heterogeneity; non-negative matrix factorization (NMF)

Mesh:

Year:  2020        PMID: 32181683      PMCID: PMC7185355          DOI: 10.1089/cmb.2019.0302

Source DB:  PubMed          Journal:  J Comput Biol        ISSN: 1066-5277            Impact factor:   1.479


  56 in total

Review 1.  A mutator phenotype in cancer.

Authors:  L A Loeb
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

Review 2.  Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.

Authors:  Takumi Kiwamoto; Norihito Kawasaki; James C Paulson; Bruce S Bochner
Journal:  Pharmacol Ther       Date:  2012-06-27       Impact factor: 12.310

3.  Inferring the Mutational History of a Tumor Using Multi-state Perfect Phylogeny Mixtures.

Authors:  Mohammed El-Kebir; Gryte Satas; Layla Oesper; Benjamin J Raphael
Journal:  Cell Syst       Date:  2016-07       Impact factor: 10.304

4.  Genome-wide copy number analysis of single cells.

Authors:  Timour Baslan; Jude Kendall; Linda Rodgers; Hilary Cox; Mike Riggs; Asya Stepansky; Jennifer Troge; Kandasamy Ravi; Diane Esposito; B Lakshmi; Michael Wigler; Nicholas Navin; James Hicks
Journal:  Nat Protoc       Date:  2012-05-03       Impact factor: 13.491

5.  Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.

Authors:  Geraldine O'Sullivan Coyne; Naoko Takebe; Alice P Chen
Journal:  Curr Probl Cancer       Date:  2017-02-11       Impact factor: 3.187

6.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

7.  Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis.

Authors:  Verena Körber; Jing Yang; Pankaj Barah; Yonghe Wu; Damian Stichel; Zuguang Gu; Michael Nai Chung Fletcher; David Jones; Bettina Hentschel; Katrin Lamszus; Jörg Christian Tonn; Gabriele Schackert; Michael Sabel; Jörg Felsberg; Angela Zacher; Kerstin Kaulich; Daniel Hübschmann; Christel Herold-Mende; Andreas von Deimling; Michael Weller; Bernhard Radlwimmer; Matthias Schlesner; Guido Reifenberger; Thomas Höfer; Peter Lichter
Journal:  Cancer Cell       Date:  2019-03-21       Impact factor: 31.743

8.  Tumor heterogeneity and drug resistance.

Authors:  D L Dexter; J T Leith
Journal:  J Clin Oncol       Date:  1986-02       Impact factor: 44.544

9.  Pan-cancer patterns of somatic copy number alteration.

Authors:  Travis I Zack; Stephen E Schumacher; Scott L Carter; Andre D Cherniack; Gordon Saksena; Barbara Tabak; Michael S Lawrence; Cheng-Zhong Zhsng; Jeremiah Wala; Craig H Mermel; Carrie Sougnez; Stacey B Gabriel; Bryan Hernandez; Hui Shen; Peter W Laird; Gad Getz; Matthew Meyerson; Rameen Beroukhim
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

Review 10.  Targeting cellular pathways in glioblastoma multiforme.

Authors:  Joshua R D Pearson; Tarik Regad
Journal:  Signal Transduct Target Ther       Date:  2017-09-29
View more
  4 in total

1.  Joint Clustering of Single-Cell Sequencing and Fluorescence In Situ Hybridization Data for Reconstructing Clonal Heterogeneity in Cancers.

Authors:  Xuecong Fu; Haoyun Lei; Yifeng Tao; Kerstin Heselmeyer-Haddad; Irianna Torres; Michael Dean; Thomas Ried; Russell Schwartz
Journal:  J Comput Biol       Date:  2021-10-05       Impact factor: 1.479

2.  Semi-deconvolution of bulk and single-cell RNA-seq data with application to metastatic progression in breast cancer.

Authors:  Haoyun Lei; Xiaoyan A Guo; Yifeng Tao; Kai Ding; Xuecong Fu; Steffi Oesterreich; Adrian V Lee; Russell Schwartz
Journal:  Bioinformatics       Date:  2022-06-24       Impact factor: 6.931

3.  Reconstructing tumor clonal lineage trees incorporating single-nucleotide variants, copy number alterations and structural variations.

Authors:  Xuecong Fu; Haoyun Lei; Yifeng Tao; Russell Schwartz
Journal:  Bioinformatics       Date:  2022-06-24       Impact factor: 6.931

4.  Robust and accurate deconvolution of tumor populations uncovers evolutionary mechanisms of breast cancer metastasis.

Authors:  Yifeng Tao; Haoyun Lei; Xuecong Fu; Adrian V Lee; Jian Ma; Russell Schwartz
Journal:  Bioinformatics       Date:  2020-07-01       Impact factor: 6.937

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.